Shoulder dystocia management blamed for brachial plexus injury and brain damage
A New York woman delivered her child in 2003 with a shoulder dystocia. After delivery, the infant was diagnosed with a brachial plexus injury and subsequently was found to have brain damage, with delays in speech and swallowing. In her lawsuit, the woman claimed that the 8 or 9 minutes that it took to relieve the dystocia resulted in asphyxiation of the infant.
The physician claimed that the dystocia had been relieved within 2 minutes with the use of McRoberts' maneuver and the application of suprapubic pressure. The defense argued that only minimal force was applied to relieve the shoulder dystocia, that the fetal heart rate monitoring did not indicate any oxygen deprivation, and that the infant had good Apgars of 7 and 8. She contended that the developmental delays and problems did not appear until the second year of life and were because of autism.
The jury found the physician and her group 75% liable for the injuries, and the hospital was charged with 25% responsibility. The patient was awarded damages of $60.9 million.
MS COLLINS is an attorney specializing in medical malpractice in Long Beach, California. She welcomes feedback on this column via e-mail to dawncfree@gmail.com
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
